In addition to this, Mehta et al. showed that HCC patients who had low AFP levels (< 500 ng/mL) after locoregional therapies like TACE were associated with lower transplant dropouts and post-transplant recurrence [74]. The gene discussed is AFP; the disease is hepatocellular carcinoma.